Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
Geethalakshmi A, Karki R, Jha SK, Venkatesh DP, Nikunj B.
Geethalakshmi A, et al.
Curr Drug Deliv. 2012 Mar;9(2):197-204. doi: 10.2174/156720112800234530.
Curr Drug Deliv. 2012.
PMID: 22283647
The present work describes the formulation and evaluation of an ophthalmic delivery system of an antiglaucomal agent, brimonidine tartrate based on the concept of ion-activated in situ gelation. Gelrite was used as the gelling agent, which gels in the presence of mono or d …
The present work describes the formulation and evaluation of an ophthalmic delivery system of an antiglaucomal agent, brimonidine tartrate b …